Biomarin Pharmaceutical Inc (BMRN)

Current ratio

Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Total current assets US$ in thousands 3,854,540 3,805,330 3,467,900 3,232,430 3,056,590 3,259,630 2,985,010 2,956,090 2,955,310 2,950,120 2,842,100 2,751,460 2,682,700 2,517,600 2,394,020 2,274,380 2,311,570 2,357,840 2,288,770 2,342,220
Total current liabilities US$ in thousands 798,438 684,247 628,213 606,988 715,658 1,067,340 1,087,900 1,177,020 1,163,220 597,231 598,231 588,884 521,020 464,727 490,418 539,822 514,898 443,344 430,035 492,548
Current ratio 4.83 5.56 5.52 5.33 4.27 3.05 2.74 2.51 2.54 4.94 4.75 4.67 5.15 5.42 4.88 4.21 4.49 5.32 5.32 4.76

September 30, 2025 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $3,854,540K ÷ $798,438K
= 4.83


Peer comparison

Sep 30, 2025

Company name
Symbol
Current ratio
Biomarin Pharmaceutical Inc
BMRN
4.83
Arrowhead Pharmaceuticals Inc
ARWR
4.86
Regeneron Pharmaceuticals Inc
REGN
4.06